On the other hand, we found that single treatment with PIP resulted in a significant suppression in ALDH-1 levels both in vitro and in vivo, and combining PIP to DOX achieved the lowest protein levels in cell lysates and tumor tissue homogenates as well as its immunoreactivity in tissue sections. Here, ALDH1A1 is linked to neoplasm.